Amgen (NASDAQ: AMGN) announced presentations of new clinical data for its rare autoimmune and inflammatory disease treatments at the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE